Organochlorine

Reactivator name Formula Structure
K868

C15H16Br2Cl2N4O2 || C15H16Cl2N4O2+2

CHEMBL3360487-7h

C27H34N4O3

Oxime-20

C23H25N2O3+

CBIO

C15H17ClN3O

K869

C16H19Br2ClN4O2

Cl-HIN

C8H5ClN2O2

Amodiaquine

C20H22ClN3O

SP-134

C14H16Cl2N2O

SAD-128

C20H30Cl2N2O

K027-Cl2

C15H16Cl2N4O2+

K870

C16H16Cl2N4O2

benzyl-pyridinium-4-methyltrichloroacetimidate

C15H14Cl3N2O

TAB2OH

C10H15ClN2O2

ICD-467

C11H19ClN4O4

Benzyl-P2A

C13H13ClN2O

HGG-52

C19H25Cl2N3O3

HI-6

C14H16Cl2N4O3 || C16H22N4O9S2

HS-3

C14H16Cl2N4O3

HS-6

C14H16Cl2N4O3

Tacrine-pyridinealdoxime-2

C23H25ClN4O2

pro-2PAM

C7H11ClN2O

Toxogonin

C14H16Cl2N4O3

K868

C15H16Br2Cl2N4O2 || C15H16Cl2N4O2+2

CHEMBL3360487-7h

C27H34N4O3

Oxime-20

C23H25N2O3+

CBIO

C15H17ClN3O

K869

C16H19Br2ClN4O2

Cl-HIN

C8H5ClN2O2

Amodiaquine

C20H22ClN3O

SP-134

C14H16Cl2N2O

SAD-128

C20H30Cl2N2O

K027-Cl2

C15H16Cl2N4O2+

K870

C16H16Cl2N4O2

benzyl-pyridinium-4-methyltrichloroacetimidate

C15H14Cl3N2O

TAB2OH

C10H15ClN2O2

ICD-467

C11H19ClN4O4

Benzyl-P2A

C13H13ClN2O

HGG-52

C19H25Cl2N3O3

HI-6

C14H16Cl2N4O3 || C16H22N4O9S2

HS-3

C14H16Cl2N4O3

HS-6

C14H16Cl2N4O3

Tacrine-pyridinealdoxime-2

C23H25ClN4O2

pro-2PAM

C7H11ClN2O

Toxogonin

C14H16Cl2N4O3

K868

C15H16Br2Cl2N4O2 || C15H16Cl2N4O2+2

CHEMBL3360487-7h

C27H34N4O3

Oxime-20

C23H25N2O3+

CBIO

C15H17ClN3O

K869

C16H19Br2ClN4O2

Cl-HIN

C8H5ClN2O2

Amodiaquine

C20H22ClN3O

SP-134

C14H16Cl2N2O

SAD-128

C20H30Cl2N2O

K027-Cl2

C15H16Cl2N4O2+

K870

C16H16Cl2N4O2

benzyl-pyridinium-4-methyltrichloroacetimidate

C15H14Cl3N2O

TAB2OH

C10H15ClN2O2

ICD-467

C11H19ClN4O4

Benzyl-P2A

C13H13ClN2O

HGG-52

C19H25Cl2N3O3

HI-6

C14H16Cl2N4O3 || C16H22N4O9S2

HS-3

C14H16Cl2N4O3

HS-6

C14H16Cl2N4O3

Tacrine-pyridinealdoxime-2

C23H25ClN4O2

pro-2PAM

C7H11ClN2O

Toxogonin

C14H16Cl2N4O3